References analysis of the Wikipedia article "Transtiretina" in the Galician version

doi.org (Global: 2^nd place; Galician: 7^th place)

dx.doi.org

Sousa MM, Cardoso I, Fernandes R, Guimarães A, Saraiva MJ (decembro de 2001). "Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates". Am. J. Pathol. 159 (6): 1993–2000. PMC 1850610. PMID 11733349. doi:10.1016/s0002-9440(10)63050-7.

Razavi H, Palaninathan SK, Powers ET, Wiseman RL, Purkey HE, Mohamedmohaideen NN, Deechongkit S, Chiang KP, Dendle MT, Sacchettini JC, Kelly JW (xuño de 2003). "Benzoxazoles as transthyretin amyloid fibril inhibitors: synthesis, evaluation, and mechanism of action". Angew. Chem. Int. Ed. Engl. 42 (24): 2758–61. PMID 12820260. doi:10.1002/anie.200351179.

Sekijima Y, Dendle MA, Kelly JW (decembro de 2006). "Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis". Amyloid 13 (4): 236–49. PMID 17107884. doi:10.1080/13506120600960882.

Adamski-Werner SL, Palaninathan SK, Sacchettini JC, Kelly JW (xaneiro de 2004). "Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis". J. Med. Chem. 47 (2): 355–74. PMID 14711308. doi:10.1021/jm030347n.

Vilaro M, Arsequell G, Valencia G, Ballesteros A, Barluenga J, Nieto J, Planas A, Almeida R, Saraiva MJ (2007). "Reengineering TTR amyloid inhibition properties of diflunisal". En Seldin DC, Skinner M, Berk JL, Connors LH. XIth International Symposium on Amyloidosis. Boca Raton: CRC. pp. 205–207. ISBN 978-1-4200-4281-8. doi:10.1201/9781420043358.ch69.

Baures PW, Oza VB, Peterson SA, Kelly JW (xullo de 1999). "Synthesis and evaluation of inhibitors of transthyretin amyloid formation based on the non-steroidal anti-inflammatory drug, flufenamic acid". Bioorg. Med. Chem. 7 (7): 1339–47. PMID 10465408. doi:10.1016/S0968-0896(99)00066-8.

Purkey HE, Palaninathan SK, Kent KC, Smith C, Safe SH, Sacchettini JC, Kelly JW (decembro de 2004). "Hydroxylated polychlorinated biphenyls selectively bind transthyretin in blood and inhibit amyloidogenesis: rationalizing rodent PCB toxicity". Chem. Biol. 11 (12): 1719–28. PMID 15610856. doi:10.1016/j.chembiol.2004.10.009.

Foss TR, Wiseman RL, Kelly JW (novembor de 2005). "The pathway by which the tetrameric protein transthyretin dissociates". Biochemistry 44 (47): 15525–33. PMID 16300401. doi:10.1021/bi051608t.

Zeldenrust SR, Benson MD (2010). "Familial and senile amyloidosis caused by transthyretin". En Ramirez-Alvarado M, Kelly JW, Dobson C. Protein misfolding diseases: current and emerging principles and therapies. Nova York: Wiley. pp. 795–815. ISBN 978-0-471-79928-3. doi:10.1002/9780470572702.ch36.

Westermark P, Sletten K, Johansson B, Cornwell GG (abril de 1990). "Fibril in senile systemic amyloidosis is derived from normal transthyretin". Proc. Natl. Acad. Sci. U.S.A. 87 (7): 2843–5. Bibcode:1990PNAS...87.2843W. PMC 53787. PMID 2320592. doi:10.1073/pnas.87.7.2843.

Andrade C (setembro de 1952). "A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves". Brain 75 (3): 408–27. PMID 12978172. doi:10.1093/brain/75.3.408.

Coelho T (outubro de 1996). "Familial amyloid polyneuropathy: new developments in genetics and treatment". Curr. Opin. Neurol. 9 (5): 355–9. PMID 8894411. doi:10.1097/00019052-199610000-00007.

Jacobson DR, Pastore RD, Yaghoubian R, Kane I, Gallo G, Buck FS, Buxbaum JN (febreiro de 1997). "Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans". N. Engl. J. Med. 336 (7): 466–73. PMID 9017939. doi:10.1056/NEJM199702133360703.

Colon W, Kelly JW (setembro de 1992). "Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro". Biochemistry 31 (36): 8654–60. PMID 1390650. doi:10.1021/bi00151a036.

Lai Z, Colón W, Kelly JW (maio de 1996). "The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid". Biochemistry 35 (20): 6470–82. PMID 8639594. doi:10.1021/bi952501g.

Hammarström P, Wiseman RL, Powers ET, Kelly JW (xaneiro de 2003). "Prevention of transthyretin amyloid disease by changing protein misfolding energetics". Science 299 (5607): 713–6. Bibcode:2003Sci...299..713H. PMID 12560553. doi:10.1126/science.1079589.

Jiang X, Smith CS, Petrassi HM, Hammarström P, White JT, Sacchettini JC, Kelly JW (setembro de 2001). "An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured". Biochemistry 40 (38): 11442–52. PMID 11560492. doi:10.1021/bi011194d.

Šimčíková D, Heneberg P (decembro de 2019). "Refinement of evolutionary medicine predictions based on clinical evidence for the manifestations of Mendelian diseases". Scientific Reports 9 (1): 18577. Bibcode:2019NatSR...918577S. PMC 6901466. PMID 31819097. doi:10.1038/s41598-019-54976-4.

Sekijima Y, Wiseman RL, Matteson J, Hammarström P, Miller SR, Sawkar AR, Balch WE, Kelly JW (abril de 2005). "The biological and chemical basis for tissue-selective amyloid disease". Cell 121 (1): 73–85. PMID 15820680. doi:10.1016/j.cell.2005.01.018.

Saraiva MJ (1995). "Transthyretin mutations in health and disease". Hum. Mutat. 5 (3): 191–6. PMID 7599630. doi:10.1002/humu.1380050302.

Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, Wallin BG, Seymour A, Richardson S, Hawkins PN (maio de 1993). "Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis". Lancet 341 (8853): 1113–6. PMID 8097803. doi:10.1016/0140-6736(93)93127-m.

Ando Y, Suhr OB (decembro de 1998). "Autonomic dysfunction in familial amyloidotic polyneuropathy (FAP)". Amyloid 5 (4): 288–300. PMID 10036588. doi:10.3109/13506129809007303.

Li X, Buxbaum JN (2011). "Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease?". Mol Neurodegener 6 (1): 79. PMC 3267701. PMID 22112803. doi:10.1186/1750-1326-6-79.

Hammarström P, Schneider F, Kelly JW (setembro de 2001). "Trans-suppression of misfolding in an amyloid disease". Science 293 (5539): 2459–62. Bibcode:2001Sci...293.2459H. PMID 11577236. doi:10.1126/science.1062245.

Reixach N, Deechongkit S, Jiang X, Kelly JW, Buxbaum JN (marzo de 2004). "Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture". Proc. Natl. Acad. Sci. U.S.A. 101 (9): 2817–22. Bibcode:2004PNAS..101.2817R. PMC 365703. PMID 14981241. doi:10.1073/pnas.0400062101.

Huang JT, Leweke FM, Oxley D, Wang L, Harris N, Koethe D, Gerth CW, Nolden BM, Gross S, Schreiber D, Reed B, Bahn S (novembro de 2006). "Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis". PLOS Med. 3 (11): e428. PMC 1630717. PMID 17090210. doi:10.1371/journal.pmed.0030428.

Smeland S, Kolset SO, Lyon M, Norum KR, Blomhoff R (setembro de 1997). "Binding of perlecan to transthyretin in vitro". Biochem. J. 326 (3): 829–36. PMC 1218739. PMID 9307034. doi:10.1042/bj3260829.

nih.gov (Global: 4^th place; Galician: 6^th place)

ncbi.nlm.nih.gov

Foss TR, Wiseman RL, Kelly JW (novembor de 2005). "The pathway by which the tetrameric protein transthyretin dissociates". Biochemistry 44 (47): 15525–33. PMID 16300401. doi:10.1021/bi051608t.

Coelho T (outubro de 1996). "Familial amyloid polyneuropathy: new developments in genetics and treatment". Curr. Opin. Neurol. 9 (5): 355–9. PMID 8894411. doi:10.1097/00019052-199610000-00007.

Saraiva MJ (1995). "Transthyretin mutations in health and disease". Hum. Mutat. 5 (3): 191–6. PMID 7599630. doi:10.1002/humu.1380050302.

Ando Y, Suhr OB (decembro de 1998). "Autonomic dysfunction in familial amyloidotic polyneuropathy (FAP)". Amyloid 5 (4): 288–300. PMID 10036588. doi:10.3109/13506129809007303.

Albrecht, S., Rouah, E., Becker, L. E., & Bruner, J. (1991). Transthyretin immunoreactivity in choroid plexus neoplasms and brain metastases. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 4(5), 610–614. PMID 1758873

nlm.nih.gov

Prealbumin Medical Subject Headings (MeSH) na Biblioteca Nacional de Medicina dos EUA.

Transtiretina (Galician Wikipedia)

archive.org (Global: 6^th place; Galician: 8^th place)

clinicaltrials.gov (Global: 5,225^th place; Galician: 7,257^th place)

doi.org (Global: 2^nd place; Galician: 7^th place)

dx.doi.org

harvard.edu (Global: 18^th place; Galician: 38^th place)

adsabs.harvard.edu

molecularneurodegeneration.com (Global: low place; Galician: low place)

nih.gov (Global: 4^th place; Galician: 6^th place)

ncbi.nlm.nih.gov

nlm.nih.gov

Transtiretina (Galician Wikipedia)

archive.org (Global: 6th place; Galician: 8th place)

clinicaltrials.gov (Global: 5,225th place; Galician: 7,257th place)

doi.org (Global: 2nd place; Galician: 7th place)

dx.doi.org

harvard.edu (Global: 18th place; Galician: 38th place)

adsabs.harvard.edu

molecularneurodegeneration.com (Global: low place; Galician: low place)

nih.gov (Global: 4th place; Galician: 6th place)

ncbi.nlm.nih.gov

nlm.nih.gov

archive.org (Global: 6^th place; Galician: 8^th place)

clinicaltrials.gov (Global: 5,225^th place; Galician: 7,257^th place)

doi.org (Global: 2^nd place; Galician: 7^th place)

harvard.edu (Global: 18^th place; Galician: 38^th place)

nih.gov (Global: 4^th place; Galician: 6^th place)